MURRAY HILL, N.J.--(BUSINESS WIRE)--April 20, 2005--C. R. Bard,
Inc. (NYSE-BCR) today announced at its Annual Meeting of Shareholders
that President and Chief Operating Officer, John H. Weiland has been
elected to its board of directors.
Weiland, 49, joined Bard in 1996 as Group Vice President and was
promoted to Group President in 1997, with responsibility for Bard's
global Surgical, Urological, and Endoscopic Technology businesses and
Bard's worldwide manufacturing operations. He was promoted to
President and Chief Operating Officer in August, 2003. Prior to
joining the company, Weiland was Senior Vice President at Dentsply
International. He served as President and Chief Executive Officer of
Pharmacia Diagnostics and held senior management positions at American
Hospital Supply and Baxter Healthcare. In 1987, he was named a White
House Fellow and served as a Special Assistant to two members of
President Reagan's cabinet. Weiland received a B.S. in Biology from
DeSales University and an MBA from New York University.
"With his extensive knowledge and experience in the medical device
industry, John has played a leading role in the success of Bard's
operations," said Chairman and Chief Executive Officer, Timothy M.
Ring. "Bard will certainly benefit from his guidance and insight as a
member of our board of directors. I look forward to working with John
in this expanded role as we continue to pursue our strategy to achieve
consistent and reliable double-digit revenue growth and enhance
long-term shareholder value."
In addition, Bard announced today that former Chairman, President
and Chief Executive Officer, William H. Longfield has retired from the
board of directors after serving as a director since April 1990. He
joined Bard in 1989 as Executive Vice President and Chief Operating
Officer and was elected Chairman and Chief Executive Officer in 1995.
"Bill's association with Bard for 16 years has had a significant
impact on our customers, employees and shareholders," Ring said. "His
integrity and leadership fostered our culture and success and we are
grateful for his many contributions."
C. R. Bard, Inc. (www.crbard.com), headquartered in Murray Hill,
NJ, is a leading multinational developer, manufacturer and marketer of
innovative, life enhancing medical technologies in the fields of
vascular, urology and surgical specialty products.
CONTACT: C. R. Bard, Inc.
Eric J. Shick, 908-277-8413
Vice President, Investor Relations
Holly P. Glass, 703-754-2848
Vice President, Government and Public Relations
SOURCE: C. R. Bard, Inc.